scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Piramal Pharma Ltd

Feedback
Piramal Pharma Ltd

Piramal Pharma Ltd (PPLPHARMA) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 4,694,328
Mar 28, 2025 15:59 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹224.75
₹5.96 (2.72%)
₹218.71 Low
Today’s Performance
₹225.5 High
₹123.2 Low
52 Week’s Performance
₹307.9 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 2.72%
  • 1 Week -0.92%
  • 1 Month 18.36%
  • 3 Months -15.28%
  • 6 Months -1.86%
  • 1 Year 74.36%
  • 3 Years 6.60%
  • 5 Years 0.00%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.78
  • 52-Week Low (₹) 123.20
  • 52-Week High (₹) 307.90
  • Price-to-Book (X)* 3.76
  • Dividend Yield (%) 0.05
  • Price-to-Earnings (P/E) (X)* 774.14
  • Earnings Per Share (₹) 0.29
  • Sector Price Earning (X)* 33.88
  • Market Cap (₹ Cr.)* 29,796.19
  • * Vaues as of last close price

COMPETITORS

BT TV

Gold Prices Soar Above ₹91,000 per 10g as Global Rates Hit Historic $3,000/oz 5:57 Why Gold Is Skyrocketing: 5 Key Factors Behind The Surge
FY26 Market Outlook: Expert Analysis On Recovery, Trade War And Small & Mid Cap Opportunities 3:55 FY26 Market Outlook: Expert Analysis On Recovery, Trade War And Small & Mid Cap Opportunities
Explained: How India’s Judiciary Handles Allegations Against Judges 5:33 Explained: How India’s Judiciary Handles Allegations Against Judges
Sanjeev Krishan Addresses The Transformative Impact Of AI, And Emerging Technologies 7:15 Sanjeev Krishan Addresses The Transformative Impact Of AI, And Emerging Technologies
US-India Trade Talks: Which Sectors Will India Prioritize For Protection? 2:12 US-India Trade Talks: Which Sectors Will India Prioritize For Protection?
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE
Oct 31, 2023 PURCHASE
EAST BRIDGE CAPITAL MASTER FUND I LIMITED
  • Qty 33643099
  • Average Price ₹102.80
Oct 31, 2023 Sell
EAST BRIDGE CAPITAL MASTER FUND LIMITED
  • Qty 33643099
  • Average Price ₹102.80
Nov 03, 2022 Sell
ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 4050700
  • Average Price ₹166.95
Nov 03, 2022 PURCHASE
ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 4050700
  • Average Price ₹166.95
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Oct 31, 2023 Sell
EAST BRIDGE CAPITAL MASTER FUND LIMITED
  • Qty 33643099
  • Average Price ₹102.80
Oct 31, 2023 PURCHASE
EAST BRIDGE CAPITAL MASTER FUND I LIMITED
  • Qty 33643099
  • Average Price ₹102.80
Nov 01, 2022 PURCHASE
BLACKROCK ADVISORS LLC A/C THE MASTER TRUST BANK OF JAPAN L
  • Qty 310097
  • Average Price ₹158.49
Nov 01, 2022 Sell
BLACKROCK ADVISORS LLC A/C THE MASTER TRUST BANK OF JAPAN L
  • Qty 14066087
  • Average Price ₹158.88
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Piramal Pharma Ltd share price previously?
Piramal Pharma Ltd share price was up by 2.72% from the previous closing price of ₹218.79.
Who are peers of Piramal Pharma Ltd?
The peers of Piramal Pharma Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd,
Who is/are the promoter/promoters of Piramal Pharma Ltd?
The promotor/promotors of Piramal Pharma Ltd are Nandini Piramal, PETER D DEYOUNG, Neeraj Bharadwaj, Jairaj Purandare, S Rama Dorai, Peter Stevenson, Sridhar Gorthi, Vibha Paul Rishi, Vivek Valsaraj, Tanya D'Costa, Nathalie Leitch.
What has been 52-week high of Piramal Pharma Ltd stocks?
The highest price of Piramal Pharma Ltd stock is ₹307.90 in the last 52-week.
What is the share price of Piramal Pharma Ltd (PPLPHARMA) today on NSE?
As on Mar 28, 2025, Piramal Pharma Ltd (PPLPHARMA)’s share price on NSE is Rs 224.75
What is the market cap of Piramal Pharma Ltd (PPLPHARMA?)
The current market capitalisation of Piramal Pharma Ltd (PPLPHARMA) is 29,796.19 crores
What is Piramal Pharma Ltd Share symbol?
The symbol of Piramal Pharma Ltd is PPLPHARMA.
What is the PE ratio of Piramal Pharma Ltd (PPLPHARMA)?
The current PE ratio of Piramal Pharma Ltd (PPLPHARMA) is 774.14.
What is the PB ratio of Piramal Pharma Ltd (PPLPHARMA)?
The current PB ratio of Piramal Pharma Ltd (PPLPHARMA) is 3.76.
Today’s High & Low share prices of Piramal Pharma Ltd (PPLPHARMA) on NSE?
Today, the share price of Piramal Pharma Ltd (PPLPHARMA) on NSE touched a high of Rs 225.5 and a low of Rs 218.71
What price did Piramal Pharma Ltd (PPLPHARMA) shares open on the NSE today?
On NSE, the share price of Piramal Pharma Ltd (PPLPHARMA) opened at Rs 219.93
What is the 52-week high of Piramal Pharma Ltd (PPLPHARMA)?
The 52-week high price of Piramal Pharma Ltd (PPLPHARMA) is Rs 307.9
What is the 52-week low of Piramal Pharma Ltd (PPLPHARMA) ?
The 52-week low price of Piramal Pharma Ltd (PPLPHARMA) is Rs 123.2

ABOUT PIRAMAL PHARMA

Piramal Pharma Ltd, incorporated in the year 2020, has its registered office in Ground Floor Piramal Ananta, Agastya Corp.Park LBS MargKurl, Mumbai, Maharashtra, 400070, 91-22-3802-3000/4000, 91-22-3802 3884. The main industry in which Piramal Pharma Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Piramal Pharma Ltd is/are Deloitte Haskins & Sells LLP. In the main management, Nandini Piramal is chairman and Tanya D'Costa is the company secretary for Piramal Pharma Ltd.

  • NP Nandini Piramal Chairperson
  • PDD PETER D DEYOUNG Executive Director & CEO
  • NB Neeraj Bharadwaj Non Executive Director
  • JP Jairaj Purandare Independent Director
  • SRD S Rama Dorai Independent Director
  • PS Peter Stevenson Independent Director
  • SG Sridhar Gorthi Independent Director
  • VPR Vibha Paul Rishi Independent Director
  • VV Vivek Valsaraj Executive Director & CFO
  • TD Tanya D'Costa Company Sec. & Compli. Officer
  • NL Nathalie Leitch Additional Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement